The Role of Hepatocyte Growth Factor/c-Met in Chronic Rhinosinusitis with Nasal Polyps

Abstract

Hepatocyte growth factor (HGF) is a growth factor thought to attenuate Th2-driven eosinophilic airway inflammatory responses. Increased expression of HGF and its receptor c-Met in nasal polyps suggests a role in disease pathogenesis. The effect of HGF on human sinonasal epithelial cell (SNEC) responses to Th2 inflammatory cytokines in chronic rhinosinusitis with nasal polyps (CRSwNP) has not been explored.
SNECs isolated from patients with CRSwNP and control subjects were grown in cell culture at the air-liquid interface. The Th2 cytokine IL-13 was applied for 24 hours in the presence or absence of HGF. Eotaxin-3 and c-Met expression was assessed using real-time PCR, immunohistochemistry, and flow cytometry.
SNECs obtained from both CRSwNP and control subjects showed markedly increased expression of eotaxin-3 after exposure to IL-13. HGF significantly blocked IL-13-induced expression of eotaxin-3 in control SNECs, but not in SNECs derived from CRSwNP subjects.
SNECs are active participants in sinonasal mucosal immunity, expressing inflammatory mediators in response to potential pathogens and endogenous cytokines. Although Th2 cytokines can elicit expression of proeosinophilic mediators by SNECs, HGF appears to have a down-regulating effect on this response. In patients with CRSwNP, SNECs are resistant to this attenuation, showing continued IL-13-induced eotaxin-3 expression despite HGF treatment. Abnormalities in the regulation of epithelial cell responses to endogenous cytokines and growth factors may contribute to the persistent eosinophilic inflammatory state in CRSwNP.

Full text

The role of hepatocyte growth Factor/c-Met in chronic
rhinosinusitis with nasal polyps
Douglas D. Reh, M.D.#, Murugappan Ramanathan Jr., M.D.#, Babar Sultan, M.D., Yadong
Wang, B.S., Lindsey May, B.S., and Andrew P. Lane, M.D.
Department of Otolaryngology–Head and Neck Surgery, Johns Hopkins University School of
Medicine, Baltimore, Maryland
# These authors contributed equally to this work.
Abstract
Background: Hepatocyte growth factor (HGF) is a growth factor thought to attenuate Th2-
driven eosinophilic airway inflammatory responses. Increased expression of HGF and its receptor
c-Met in nasal polyps suggests a role in disease pathogenesis. The effect of HGF on human
sinonasal epithelial cell (SNEC) responses to Th2 inflammatory cytokines in chronic rhinosinusitis
with nasal polyps (CRSwNP) has not been explored.
Methods: SNECs isolated from patients with CRSwNP and control subjects were grown in cell
culture at the air–liquid interface. The Th2 cytokine IL-13 was applied for 24 hours in the presence
or absence of HGF. Eotaxin-3 and c-Met expression was assessed using real-time PCR,
immunohistochemistry, and flow cytometry.
Results: SNECs obtained from both CRSwNP and control subjects showed markedly increased
expression of eotaxin-3 after exposure to IL-13. HGF significantly blocked IL-13–induced
expression of eotaxin-3 in control SNECs, but not in SNECs derived from CRSwNP subjects.
Conclusion: SNECs are active participants in sinonasal mucosal immunity, expressing
inflammatory mediators in response to potential pathogens and endogenous cytokines. Although
Th2 cytokines can elicit expression of proeosinophilic mediators by SNECs, HGF appears to have
a down-regulating effect on this response. In patients with CRSwNP, SNECs are resistant to this
attenuation, showing continued IL-13–induced eotaxin-3 expression despite HGF treatment.
Abnormalities in the regulation of epithelial cell responses to endogenous cytokines and growth
factors may contribute to the persistent eosinophilic inflammatory state in CRSwNP.
Keywords
Chronic; chronic rhinosinusitis; c-Met; hepatocyte growth factor; HGF; nasal epithelial; nasal
polyps; polyps; rhinosinusitis; SNEC
Address correspondence and reprint requests to Andrew P. Lane, M.D., Department of Otolaryngology/Head and Neck Surgery, Johns
Hopkins Medicine, 601 North Caroline, Street, 6th floor; 6240, Baltimore, MD 21287-0910, alane3@jhmi.edu.
The authors have nothing to disclose pertaining to this article
HHS Public Access
Author manuscript
Am J Rhinol Allergy
. Author manuscript; available in PMC 2018 September 06.
Published in final edited form as:
Am J Rhinol Allergy
. 2010 ; 24(4): 266–270. doi:10.2500/ajra.2010.24.3485.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript

Chronic rhinosinusitis with nasal polyps (CRSwNP) is an inflammatory disease that remains
difficult to treat despite advances in medical and surgical treatment alternatives. Although
CRSwNP patients benefit from endoscopic sinus surgery (ESS),1,2 polyp recurrence rates
exceed 50% and revision surgery is required in 30% of these patients.3 Because of the
significant recidivism of this disease, long-term treatment with anti-inflammatory
medications such as oral steroids remains the mainstay in treatment for CRSwNP despite the
significant complications associated with their use. Research is clearly needed to better
understand the pathophysiology of CRSwNP to develop newer, more novel methods of
treatment.
Histologically, CRSwNP is characterized by a predominance of eosinophils, goblet cell
hyperplasia, and thickening of the basement membrane. The eosinophilic inflammation
associated with CRSwNP occurs in a milieu distinguished by the prevalence of Th2
cytokines such as IL-4, IL-5, and IL-13.4 Although the cause of the shift from Th1 to Th2
mediators in CRSwNP is not known, both host factors and external mechanisms have been
proposed.
Hepatocyte growth factor (HGF) is a potent mitogen, which acts as a stimulator for various
epithelial cell types such as those found in the liver, kidney, and in the upper airway. Its
signal is potentiated through c-Met, a tyrosine kinase receptor encoded by a proto-oncogene.
HGF and c-Met have been shown to be elevated in conditions involving acute tissue injury
such as liver injury and acute pneumonia.5 HGF and c-Met are also involved in the various
phases of wound repair such as inflammation, epithelialization, and the formation of
granulation tissue. Their role in upper airway inflammation and CRSwN has been
established by several studies. Rho
et al.
confirmed the presence of c-Met and HGF in the
submucosal glands and epithelium of nasal polyps.6 A similar study found that the
expression of these molecules is increased in inverted papillomas.7 The objective of this
study is to identify c-Met expression in human sinonasal epithelial cells (SNECs) and
determine the functional consequences of HGF stimulation in nondiseased controls and
patients with CRSwNP.
MATERIALS AND METHODS
Human Subjects
Six patients with CRSwNP and six control subjects were enrolled in the study. The research
protocol was approved through the Johns Hopkins Institutional Review process, and all
subjects gave signed informed consent. The CRSwNP patients were defined by historical,
endoscopic, and radiographic criteria and by meeting the definition of the American
Academy of Otolaryngology–Head and Neck Surgery Chronic Rhinosinusitis Task Force.8
Specifically, the patients had continuous symptoms of rhinosinusitis as defined by the Task
Force report for >12 consecutive weeks, associated with computed tomography of the
sinuses revealing isolated or diffuse sinus mucosal thickening or air–fluid levels. Nasal
endoscopy revealed the presence of at least one sinonasal polyp before or at the time of ESS.
Surgery was only performed if a patient’s symptoms and radiographic findings failed to
resolve despite at least 6 weeks of treatment with oral antibiotics, topical corticosteroids,
Reh et al. Page 2
Am J Rhinol Allergy
. Author manuscript; available in PMC 2018 September 06.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript

decongestants, and mucolytic agents, as well as 3 weeks of systemic corticosteroid. The six
control subjects had no evidence of sinus disease and were undergoing endoscopic
approaches for transnasal endoscopic pituitary surgery, cerebrospinal fluid leak repair, or
sphenoidotomy for biopsy of an isolated, noninflammatory sphenoid sinus process. Before
surgery, the CRSwNP patients received 1 week of oral prednisone. All tissue specimens
were taken from the middle turbinate, the resected uncinate process, or the anterior ethmoid
sinus. The CRSwNP specimens were carefully selected to avoid polyps or tissue that was
grossly polypoid in appearance.
Epithelial Cell Dissociation from Human Sinus Mucosal Tissue
Mucosal tissue removed during ESS was collected into sterile cold transferred to phosphate-
buffered saline (PBS) supplemented by penicillin (100 U/mL; Gibco, Gaithersburg, MD),
streptomycin (100 μg/ mL, Gibco), amphotericin B (2.5 μg/mL, Gibco), and gentamicin (50
μg/mL, Gibco). The samples were placed through a cell strainer (BD Falcon, San Jose, CA)
into Ham’s F12 media containing 0.01% protease Sigma type XIV (Sigma, St. Louis, MO)
and supplemented with antibiotics as mentioned previously. Digestion in protease was
performed at 4°C overnight, with separation of cells by agitation the following day. The cells
were separated by straining into a conical tube to which fetal bovine serum (FBS) was added
to a final concentration of 10%, inactivating the protease. The cells were centrifuged twice at
1300 rpm for 10 minutes, after which the supernatant was aspirated and discarded. The
washed passage 0 (P0) SNEC cells were then seeded, at a density ≥1.5 ×104 cells/cm2, onto
Vitrogen 100– coated (1:75 in sterile water; Cohesion, Palo Alto, CA) P-100 dishes in
bronchial epithelium growth medium (BEGM), as previously described by our group.9 The
cells were then grown at 37°C for 24 hours and then washed with Hank’s balanced salt
solution (HBSS) (Biofluids, Rockville, MD) to remove debris. The media was then changed
every 48 hours until the cells reached confluence.
SNEC Culture at the Air–Liquid Interface (ALI)
Confluent cells were washed with HBSS before trypsinization and then treated at 37°C for 4
minutes with a solution containing 0.2% trypsin (Sigma), 1% polyvinylpyrrolidone (Sigma),
and 0.02% EGTA (Sigma) in HBSS. The trypsin was then neutralized by the addition of an
equal volume of cold soybean trypsin inhibitor at a concentration of 1 mg/mL in Ham’s F12
media. Dissociated cells were washed and resuspended into BEGM media and plated into
human type IV placental collagen (type VI; Sigma)–coated 12-well Falcon filter inserts (0.4-
μm pore size; Becton Dickinson, Franklin Lakes, NJ). Although some P1 cells were directly
used for flow cytometry, other P1 cells were grown to confluence with BEGM, above (1 mL)
and below (2 mL) the cells. When confluent, medium is removed from above the cultures
and the medium below the inserts was changed to ALI medium consisting of LHC Basal
Medium/DMEM-H (50:50; Gibco) containing the same concentrations of additives as
BEGM with the exception that the concentration of epidermal growth factor is reduced to
0.63 ng/mL and amphotericin B is omitted. Each set of cultures came from a separate patient
source and was maintained at the ALI with the apical surfaces remaining free of medium for
at least 3 weeks before study.
Reh et al. Page 3
Am J Rhinol Allergy
. Author manuscript; available in PMC 2018 September 06.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript

Stimulation of Cells
Ciliated epithelial cells at the ALI were stimulated basolaterally with 10 ng/mL of IL-13
and/or 50 ng/mL of HGF diluted in ALI medium for 24 hours.
RNA Extraction/Reverse Transcription
Total RNA was extracted using the RNeasy Kit by Qiagen (Valencia, CA) according to the
manufacturer’s directions. RNA was quantified spectrophotometrically and visualized by
staining with ethidium bromide to determine RNA integrity. Absorbance ratios at 260/280
nm were >1.80 for all samples studied. Isolated mRNA was reverse transcribed with random
hexamer primers using the Qiascript Reverse Transcription kit (Qiagen).
Real-Time Polymerase Chain Reaction (PCR)
Real-time PCR was performed in a Light-Cycler 1.2 (Roche, Indianapolis, IN) using the
SYBR Green PCR Kit (Qiagen). The 18S was used as a housekeeping gene with which to
normalize expression and was determined in previous experiments to be stable across
control and CRS sinonasal tissue samples. The reaction mix consisted of 0.8 μg of total
RNA (target genes) or 0.08 μg of total RNA (18S RNA), 10μL of QuantiTect SYBR Green
PCR, 1.5–5 mol/L of target primers, or 1.0 mol/L of 18S rRNA primers, in total volume of
20 μL. All primers (18S, sense 5’ GTAACCCGTTGAACCCCATT-3’, antisense
5’CCATCCAATCGGTAGTAGCG-3’); c-Met, sense 5’GGCATGTCAACATCGCTCTA-3’,
antisense 5 GTTGCAGATTCAGCTGTTGC-3’; eotaxin-3, sense 5
AACTCCGAAACAATTGTACTCA-3’, antisense 3 GTAACTCTGGGAGGAAACACC-5’)
were commercially synthesized by Invitrogen (Carlsbad, CA). The cycle parameters used
were 95°C for 15 minutes to activate Taq polymerase, followed by 45 cycles at 94°C for 15
seconds, 60°C for 30 seconds, and 72°C for 30 seconds. Amplicon expression in each
sample was normalized to its 18S RNA content. The level of expression of target mRNA
was determined as the delta CT (ΔCT). The CT method uses the difference in CT value
obtained between a normalizing housekeeping gene (18S) and the target gene to calculate
relative quantification (ΔCT the difference in threshold cycles for target and housekeeping
gene). This normalization reduces sample-to-sample variations in signal strength. A decrease
in the ΔCT by 1 U equals a doubling of the level of the target gene. Consistent use of the
quantities of total RNA described previously (800 and 80 ng for target molecules and 18S
RNA, respectively) resulted in highly reproducible real-time PCR cycle thresholds for each
of the amplicons across all cell samples. Negative controls, consisting of reaction mixtures
containing all components except target RNA, were included with each PCR run.
Flow Cytometry
Adherent cells SNECs were detached from 6-well plates as described previously and
transferred into 1.5-mL microfuge tubes at a concentration of 200,000 cells/tube. Cells were
incubated with 0.5 μL of biotinylated c-Met antibody (ebiosciences, San Diego, CA) for 30
minutes at 4°C. Cells were then centrifuged and washed twice and resuspended in cold PBS
with sodium azide and 2% FCS. Cells were then stained with polycoerythrin (PE)-
conjugated streptavidin for 30 minutes at 4°C followed by two washes and fixation with 2%
paraformaldehyde. Isotype controls consisted of PE-conjugated rat antihuman IgG
Reh et al. Page 4
Am J Rhinol Allergy
. Author manuscript; available in PMC 2018 September 06.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript

(eBiosciences). Analysis was performed on a FACS calibur flow cytometer (BD
Biosciences, San Jose, CA) and data were analyzed using CellQuest software (BD
Biosciences). Cell surface protein is expressed as the increase in mean fluorescence intensity
over background (species-specific isotype-matched control) or percentage of positive
staining cells.
Immunofluorescence and Confocal Microscopy
SNECs at the ALI were fixed in 4% paraformaldehyde for 15 minutes and washed twice in
cold PBS. Cells were then incubated with 1% bovine serum albumin in staining buffer for 30
minutes followed by incubation with antibodies to b-tubulin and c-Met (Abcam, Cambridge,
MA) diluted in 1% bovine serum albumin overnight at 4°C. After washing SNECs three
times with PBS, secondary antibody was added for 1 hour at room temperature. Cells on
inserts were then mounted on slides and imaged using a confocal microscope (LSM 510
meta, Carl Zeiss Microimaging, Thornwood, NY). Images are flattened z stacks taken at 1-
μm intervals.
Statistical Analysis
Raw data from real-time PCR were entered into a spreadsheet (Excel; Microsoft Corp.,
Redmond, WA). Statistical analysis was performed using a software program (Excel;
Microsoft Corp.). Data are expressed as mean ± SEM. Statistical significance of differences
was determined using the
t
-test. Differences were considered statistically significant at
p
<
0.05.
RESULTS
SNECs in Culture Express c-Met by Immunofluorescence and Flow Cytometry
SNECs from both CRSwNP and control patients express c-Met mRNA detected by reverse
transcription-PCR and protein assessed by immunofluorescence and flow cytometry (Fig. 1;
95–100%). Flow cytometry was performed on submerged SNECs and therefore resemble the
basal layer of cells in ciliated respiratory epithelium. Immunofluorescence of SNECs at the
ALI shows c-Met staining primarily in the basolateral nonciliated epithelial cells.
Additionally, stimulation of SNECs from both groups with the potent Th2 cytokine, IL-13,
does not further augment c-Met expression.
HGF Down-Regulates c-Met Protein in CRSwNP
To assess the effects of HGF on c-Met expression, SNECs at the ALI were stimulated with
HGF. Subsequently, cDNA derived from these cells and real-time PCR was used to quantify
c-Met levels. There is no statistically significant difference in c-Met mRNA levels between
control and CRSwNP patients after HGF stimulation. To examine protein expression, flow
cytometry was used to measure c-Met in CRSwNP and control SNECs stimulated with HGF
before growth at the ALI. We observed a substantial decrease in membrane bound c-Met in
CRSwNP (50%; range, 40–60%) but not in control patients (95%; Figs. 2 and 3).
Reh et al. Page 5
Am J Rhinol Allergy
. Author manuscript; available in PMC 2018 September 06.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript

HGF Down-Regulates Eotaxin-3 Levels in Control Patients but not CRSwNP
Although SNECs at baseline express low levels of eotaxin-3, IL-13 stimulation potentiates
eotaxin-3 secretion. Therefore, to assess the functional consequences of HGF stimulation,
SNECs at the ALI were exposed to a combination of IL-13 and HGF and eotaxin-3 levels
were determined by real-time PCR. SNECs from CRSwNP and control patients produced
similar amounts of eotaxin after IL-13 stimulation. However, HGF blocked IL-13–induced
expression of eotaxin-3 in control SNECs by fourfold (two-cycle real-time PCR threshold,
p
< 0.02), but not in SNECs derived from CRSwNP subjects (Fig. 4).
DISCUSSION
Although CRSwNP inflammation is produced in part by an exaggerated production of Th2
cytokines and mediators, the cause has not been well defined. Multiple groups have
proposed that an abnormal immune response may occur as a result of exposure to
microorganisms and/or their products such as fungi, staphylococci, or pseudomonal
biofilms.10–15 Exotoxins from
Staphylococcus aureus
, acting as superantigens, are able to
induce a polyclonal T-cell response that activates larger subpopulations of T cells than a
typical antigen.
S. aureus
toxins have been shown to increase production of Th2 cytokines
such as IL-4 and IL-5, leading to increased lymphocytic and eosinophilic infiltration.11
Bachert
et al.
showed the presence of IgE antibodies to the
S. aureus
superantigens, SEA and
SEB, in nasal polyps.12–14 The presence of
S. aureus
superantigens in nasal polyps suggests
a potential role for exogenous factors as a contributor to the Th2 immune response in
CRSwNP. However, these innocuous and ubiquitous agents, such as
S. aureus
and fungi, do
not typically generate an exaggerated Th2 response in a healthy host, which alludes to the
presence of an additional, endogenous abnormality in affected CRSwNP patients. These
findings have been the primary impetus to better understand host gene expression in
CRSwNP.
SNECs are active participants in mucosal immunity, expressing inflammatory mediators in
response to potential pathogens and endogenous cytokines. Although many studies have
implicated a dysregulation of epithelial innate immune genes in potentiating Th2
inflammation, few studies have examined the role of growth factors and genes involved in
repair.15 In 2006, Rho
et al.
described the overexpression of c-Met, a proto-oncogene
expressed on epithelial cells, and its growth factor ligand HGF in nasal polyps compared
with inferior turbinate mucosa.6 Subsequently, Stankovic
et al.
performed a gene chip
microarray analysis of nasal polyps compared with normal mucosa and also found
overexpression of c-Met.16
Although the focus of research on c-Met/HGF has been on neoplastic disease, very little is
known about its role in sustaining chronic inflammation. HGF, the ligand for c-Met (or HGF
receptor), is a potent mitogen and morphogen that promotes motility, proliferation, and
differentiation in a number of different cell types, including upper airway epithelial cells.17
In this study, we show the expression of c-Met mRNA and protein in SNECs cultured from
control and CRSwNP patients. At baseline, close to 100% of SNECs from controls and
CRSwNP express membrane bound c-Met. Interestingly, both Rho
et al.
and Stankovic
et al.
Reh et al. Page 6
Am J Rhinol Allergy
. Author manuscript; available in PMC 2018 September 06.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript

found an increased expression of c-Met in the submucosal glandular epithelium and the
basal layers of respiratory epithelium in nasal polyps compared with inferior turbinate
mucosa from controls. This difference may perhaps be explained by the fact that our study
examined c-Met expression in SNECs isolated from mucosal tissue with polypoid
inflammation and not whole nasal polyps that contain large amounts of submucosal glands.
Additionally, when CRSwNP SNECs are stimulated with HGF, there is a profound decrease
in membrane bound c-Met protein but not in mRNA expression. These findings are
consistent with a study by Shen
et al.
, who quantified c-Met mRNA and protein levels
via
Northern and Western blots in tracheal epithelial cells after stimulation with HGF. This
study found that while mRNA levels do not change with HGF stimulation, total protein
expression was decreased.18 Additionally, our study found that the potent Th2 cytokine
IL-13 does not modulate or augment mRNA or protein expression of c-Met in SNECs from
either control or CRSwNP patients.
Eotaxins are among the primary chemokines produced by epithelial cells that act as potent
chemotactic factors for eosinophilic inflammation.19 A few studies in the literature have
reported the effects of HGF on eosinophilic inflammation in bronchial asthma, another
Th2mediated disease that shares many similarities with CRSwNP. Okunishi
et al.
in 2009
examined the effect of HGF on asthmatic airway inflammation in the ovalbumin-allergic
mouse model, before ovalbumin inhalation. They found that intratracheal administration of
HGF profoundly decreased eosinophilic airway inflammation and downregulated antigen
presentation to T cells in the lung. 17 Similarly, Ito
et al.
show that HGF treatment of
eosinophils suppressed CD69, a marker of eosinophil activation, and also suppressed the
release of effector inflammatory molecules such as reactive oxygen species and eosinophil-
derived neurotoxin.20 To study the functional consequences of HGF stimulation on the nasal
epithelium, we stimulated SNECs from controls and CRSwNP with IL-13 and HGF. Our
study indicates that HGF attenuates IL-13–induced eotaxin production from SNECs in
control patients, but not CRSwNP. This suggests that the ordinary ability of HGF to down-
regulate Th2 inflammation is dysfunctional in the nasal epithelium in CRSwNP. To our
knowledge, this is a novel finding not previously reported. The decreased c-Met receptor
found after HGF stimulation in CRSwNP may perhaps explain the inability of HGF to
attenuate IL-13–induced eotaxin production in this population. Further research is needed to
explore this mechanism.
One inherent difference in our methodology is that preoperative systemic corticosteroids
were given to the CRSwNP patients but not to the control patients. Although it is possible
that treatment with steroids potentially impacts the expression of c-Met, it is important to
note that flow cytometric analysis of SNECs grown in submerged culture showed similar c-
Met expression between the two groups. With respect to SNECs grown at the ALI, because
this culture model system involves multiple weeks of growth and differentiation in media
free of corticosteroids, it seems unlikely that there would be significant residual effects from
prior exposure
in vivo
. However, it can not be ruled out that remote exposure to steroids
might have a small effect on the subsequent physiology of c-Met
in vitro
.
Although our study population was relatively limited and understanding that cell culture
systems imperfectly model the
in vivo
environment, these findings highlight that
Reh et al. Page 7
Am J Rhinol Allergy
. Author manuscript; available in PMC 2018 September 06.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript

abnormalities in the regulation of epithelial cell responses to endogenous cytokines and
growth factors may contribute to the persistent eosinophilic inflammatory state in CRSwNP.
Because mucosal innate immunity is closely tied to growth and repair responses,
dysfunction of the c-Met/HGF pathway may represent a mechanism through which
persistent Th2 inflammation can be propagated by the sinonasal epithelium. A better
understanding of how growth factors and their signaling pathways interact with epithelial
cell innate immune function may contribute to new therapeutic strategies for CRSwNP.
REFERENCES
1. Poetker DM, Mendolia-Loffredo S, and Smith TL. Outcomes of endoscopic sinus surgery for
chronic rhinosinusitis associated with sinonasal polyposis. Am J Rhinol 21:84–88, 2007. [PubMed:
17283567]
2. Bhattacharyya N Influence of polyps on outcomes after endoscopic sinus surgery. Laryngoscope
117:1834–1838, 2007. [PubMed: 17690616]
3. Wynn R, and Har-El G. Recurrence rates after endoscopic sinus surgery for massive sinus polyposis.
Laryngoscope 114:811–813, 2007.
4. Otto BA, and Wenzel SE. The role of cytokines in chronic rhinosinusitis with nasal polyps. Curr
Opin Otolaryngol Head Neck Surg 16:270–274, 2008. [PubMed: 18475084]
5. Matsumoto K, and Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J
Biochem 119:591–600, 1996. [PubMed: 8743556]
6. Rho HS, Lee SH, Lee HM, et al. Overexpression of hepatocyte growth factor and its receptor c-Met
in nasal polyps. Arch Otolaryngol Head Neck Surg 132:985–989, 2006. [PubMed: 16982975]
7. Choi JI, Lee SH, Lee HM, Lee SH, et al. Expression and localization of hepatocyte growth factor
and its receptor c-Met in inverted papilloma. Acta Otolaryngol 126:724–729, 2006. [PubMed:
16803712]
8. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: Establishing definitions for clinical
research and patient care. Otolaryngol Head Neck Surg 131(suppl 6):S1–S62, 2004. [PubMed:
15577816]
9. Lane AP, Saatian B, Yu XY, and Spannhake EW. mRNA for genes associated with antigen
presentation are expressed by human middle meatal epithelial cells in culture. Laryngoscope
114:1827–1832, 2004. [PubMed: 15454780]
10. Ponikau JU, Sherris DA, Kephart GM, et al. The role of ubiquitous airborne fungi in chronic
rhinosinusitis. Curr Allergy Asthma Rep 5:472–476, 2005. [PubMed: 16216172]
11. Bachert C, Gevaert P, Zhang N, et al. Superantigens and nasal polyps. Curr Allergy Asthma Rep
3:523–531, 2003. [PubMed: 14531975]
12. Bendouah Z, Barbeau J, Hamad WA, and Desrosiers M. Biofilm formation by Staphylococcus
aureus and
Pseudomonas aeruginosa
is associated with unfavorable evolution after surgery for
chronic sinusitis and nasal polyposis. Otolaryngol Head Neck Surg 134:991–996, 2006. [PubMed:
16730544]
13. Palmer JN. Bacterial biofilms: Do they play a role in chronic rhinosinusitis? Otolaryngol Clin
North Am 38:1193–1201, 2005. [PubMed: 16326178]
14. Bernstein JM, Ballow M, Schlievert PM, et al. A superantigen hypothesis for the pathogenesis of
chronic hyperplastic sinusitis with massive nasal polyposis. Am J Rhinol 17:321–326, 2003.
[PubMed: 14750606]
15. Ramanathan M, Lee WK, Spannhake EW, and Lane AP. Th2 cytokines associated with chronic
rhinosinusitis with polyps down-regulate the antimicrobial immune function of human sinonasal
epithelial cells. Am J Rhinol 22:115–121, 2008. [PubMed: 18416964]
16. Stankovic KM, Goldsztein H, Reh DD, et al. Gene expression profiling of nasal polyps associated
with chronic sinusitis and aspirinsensitive asthma. Laryngoscope 118:881–889, 2008. [PubMed:
18391768]
Reh et al. Page 8
Am J Rhinol Allergy
. Author manuscript; available in PMC 2018 September 06.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript

17. Okunishi K, Sasaki O, Okasora T, et al. Intratracheal delivery of hepatocyte growth factor directly
attenuates allergic airway inflammation in mice. Int Arch Allergy Immunol 149(suppl 1):14–20.
2009 (Epub June 3, 2009.) [PubMed: 19494499]
18. Shen BQ, Panos RJ, Hansen-Guzmán K, et al. Hepatocyte growth factor stimulates the
differentiation of human tracheal epithelia in vitro. Am J Physiol 27:L1115–L1120, 1997.
19. Ferguson BJ. Categorization of eosinophilic chronic rhinosinusitis. Curr Opin Otolaryngol Head
Neck Surg 12:237–242, 2004. [PubMed: 15167036]
20. Ito W, Takeda M, Tanabe M, et al. Anti-allergic inflammatory effects of hepatocyte growth factor.
Int Arch Allergy Immunol 146(suppl 1): 82–87, 2008. [PubMed: 18504413]
Reh et al. Page 9
Am J Rhinol Allergy
. Author manuscript; available in PMC 2018 September 06.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript

Figure 1.
Sinonasal epithelial cells (SNECs) express membrane bound c-Met in both chronic
rhinosinusitis (CRS) and control patients. (A) Flow cytometric analysis of control SNECs
(grown in submerged culture) stained with c-Met phycoerythrin. Ninety-eight percent of the
cells express c-Met protein on the surface of each cell. Each dot on this diagram represents
one epithelial cell that stained positive for c-Met; the fluorescence intensity on the y-axis is
indicative of the number of membrane bound c-Met receptors on each cell. (B)
Immunofluorescence and confocal microscopy of SNECs at the air–liquid interface (ALI)
from CRS with nasal polyps (wNP) stained with c-Met and tubulin (a marker for ciliated
epithelial cells). There are few areas of double staining, indicating that c-Met is primarily
expressed in basolateral cells that are nonciliated.
Reh et al. Page 10
Am J Rhinol Allergy
. Author manuscript; available in PMC 2018 September 06.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript

Figure 2.
Flow cytometric sinonasal epithelial cell (SNEC) c-Met expression after hepatocyte growth
factor (HGF) stimulation. SNECs from control and chronic rhinosinusitis with nasal polyp
(CRSwNP) patients were stimulated with 50 ng/mL of HGF and stained with c-Met PE
antibody and analyzed by flow cytometry. At baseline both controls and CRSwNP patients
express 95–100% of c-Met. The panel on the left shows that controls stimulated with HGF
do not modify c-Met expression. CRSwNP SNECs stimulated with HGF is depicted on the
right, which shows nearly a 50% reduction of membrane bound c-Met protein.
Reh et al. Page 11
Am J Rhinol Allergy
. Author manuscript; available in PMC 2018 September 06.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript

Figure 3.
Reduced expression of c-Met after hepatocyte growth factor (HGF) stimulation in chronic
rhinosinusitis with nasal polyps (CRSwNP). Flow histogram depicting sinonasal epithelial
cells (SNECs) from CRSwNP before and after HGF stimulation as labeled. Fluorescence
intensity decreases after HGF stimulation, indicating a reduction in membrane bound c-Met
expression.
Reh et al. Page 12
Am J Rhinol Allergy
. Author manuscript; available in PMC 2018 September 06.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript

Figure 4.
Eotaxin-3 production from sinonasal epithelial cells (SNECs). SNECs at the air–liquid
interface (ALI) from control and chronic rhinosinusitis (CRS) patients were stimulated with
either 10 ng/mL of IL-13 alone or 50 ng/mL of hepatocyte growth factor (HGF) and 10
ng/mL of IL-13. Realtime polymerase chain reaction (PCR) was then used to measure
eotaxin-3 levels from cDNA made from cells. All values are normalized to 18S and depicted
as delta cycle thresholds. Error bars represent ± SE of the mean. HGF attenuates IL-13–
induced production of eotaxin in controls but not CRS with nasal poltps (wNPs). **This
reached statistical significance at p < 0.02.
Reh et al. Page 13
Am J Rhinol Allergy
. Author manuscript; available in PMC 2018 September 06.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript